Ahead of possible expansion into pediatric COVID-19 vaccination, CDC provides initial considerations for health care jurisdictions

The Centers for Disease Control and Prevention has released an initial document intended to assist jurisdictions across the country in planning for the distribution and administration of COVID-19 vaccines to the pediatric population. The document provides information pertaining to pediatric COVID-19 vaccines and several assumptions that can be made about the pediatric COVID-19 vaccination program. The document also highlights packaging changes and storage requirements for the Pfizer pediatric COVID-19 vaccine for children ages 5-11. AHA anticipates the availability of more detailed information in the coming days and weeks and will share those updates as new information is released.